Drug class
Pyruvate Kinase Activator
Mechanism of action
Pyruvate Kinase Activators [MoA]
General use cases
- Anemia, Hemolytic
- Anemia, Hemolytic, Congenital Nonspherocytic
- Pyruvate Metabolism, Inborn Errors
- anemia in adults with alpha- or beta-thalassemia
- hemolytic anemia in adults with pyruvate kinase (PK) deficiency
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
